Article
Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy.
ACS nano - 22 Jun 2021
Suay-Corredera Carmen, Pricolo Maria Rosaria, Velázquez-Carreras Diana, Pathak Divya, Nandwani Neha, Pimenta-Lopes Carolina, Sánchez-Ortiz David, Urrutia-Irazabal Iñigo, Vilches Silvia, Dominguez Fernando, Frisso Giulia, Monserrat Lorenzo, García-Pavía Pablo, de Sancho David, Spudich James A, Ruppel Kathleen M, Herrero-Galán Elías, Alegre-Cebollada Jorge
Abstract excerpt
Hypertrophic cardiomyopathy (HCM) is a disease of the myocardium caused by mutations in sarcomeric proteins with mechanical roles, such as the molecular motor myosin. Around half of the HCM-causing genetic variants target contraction modulator cardiac myosin-binding protein C (cMyBP-C), although the underlying pathogenic mechanisms remain unclear since many of these mutations cause no alterations in protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
